Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid

Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at t...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Apriani Apriani [verfasserIn] Fenny Ong Lian Hwa [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch ; Indonesisch

Erschienen:	2022

Schlagwörter:	covid-19 comorbid laboratory tests

Übergeordnetes Werk:	In: Jurnal Ilmu dan Teknologi Kesehatan - Poltekkes Kemenkes Jakarta III, 2022, 10(2022), 1, Seite 62-75
Übergeordnetes Werk:	volume:10 ; year:2022 ; number:1 ; pages:62-75

Links:	Link aufrufen Link aufrufen Link aufrufen Journal toc Journal toc

DOI / URN:	10.32668/jitek.v10i1.938

Katalog-ID:	DOAJ085414875

Internformat


LEADER	01000naa a22002652 4500
001	DOAJ085414875
003	DE-627
005	20230311035035.0
007	cr uuu---uuuuu
008	230311s2022 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.32668/jitek.v10i1.938 \|2 doi
035			\|a (DE-627)DOAJ085414875
035			\|a (DE-599)DOAJ36200870d36d4011953d531bd044d0e6
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng \|a ind
050		0	\|a R855-855.5
100	0		\|a Apriani Apriani \|e verfasserin \|4 aut
245	1	0	\|a Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients.
650		4	\|a covid-19
650		4	\|a comorbid
650		4	\|a laboratory tests
653		0	\|a Medical technology
700	0		\|a Fenny Ong Lian Hwa \|e verfasserin \|4 aut
773	0	8	\|i In \|t Jurnal Ilmu dan Teknologi Kesehatan \|d Poltekkes Kemenkes Jakarta III, 2022 \|g 10(2022), 1, Seite 62-75 \|w (DE-627)1826854487 \|x 23389109 \|7 nnns
773	1	8	\|g volume:10 \|g year:2022 \|g number:1 \|g pages:62-75
856	4	0	\|u https://doi.org/10.32668/jitek.v10i1.938 \|z kostenfrei
856	4	0	\|u https://doaj.org/article/36200870d36d4011953d531bd044d0e6 \|z kostenfrei
856	4	0	\|u https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938 \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2338-9095 \|y Journal toc \|z kostenfrei
856	4	2	\|u https://doaj.org/toc/2338-9109 \|y Journal toc \|z kostenfrei
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_DOAJ
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 10 \|j 2022 \|e 1 \|h 62-75

Indexfelder

author_variant	a a aa f o l h folh
matchkey_str	article:23389109:2022----::rflolbrtrtsvlenofrecvd9a
hierarchy_sort_str	2022
callnumber-subject-code	R
publishDate	2022
allfields	10.32668/jitek.v10i1.938 doi (DE-627)DOAJ085414875 (DE-599)DOAJ36200870d36d4011953d531bd044d0e6 DE-627 ger DE-627 rakwb eng ind R855-855.5 Apriani Apriani verfasserin aut Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients. covid-19 comorbid laboratory tests Medical technology Fenny Ong Lian Hwa verfasserin aut In Jurnal Ilmu dan Teknologi Kesehatan Poltekkes Kemenkes Jakarta III, 2022 10(2022), 1, Seite 62-75 (DE-627)1826854487 23389109 nnns volume:10 year:2022 number:1 pages:62-75 https://doi.org/10.32668/jitek.v10i1.938 kostenfrei https://doaj.org/article/36200870d36d4011953d531bd044d0e6 kostenfrei https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938 kostenfrei https://doaj.org/toc/2338-9095 Journal toc kostenfrei https://doaj.org/toc/2338-9109 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2022 1 62-75
spelling	10.32668/jitek.v10i1.938 doi (DE-627)DOAJ085414875 (DE-599)DOAJ36200870d36d4011953d531bd044d0e6 DE-627 ger DE-627 rakwb eng ind R855-855.5 Apriani Apriani verfasserin aut Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients. covid-19 comorbid laboratory tests Medical technology Fenny Ong Lian Hwa verfasserin aut In Jurnal Ilmu dan Teknologi Kesehatan Poltekkes Kemenkes Jakarta III, 2022 10(2022), 1, Seite 62-75 (DE-627)1826854487 23389109 nnns volume:10 year:2022 number:1 pages:62-75 https://doi.org/10.32668/jitek.v10i1.938 kostenfrei https://doaj.org/article/36200870d36d4011953d531bd044d0e6 kostenfrei https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938 kostenfrei https://doaj.org/toc/2338-9095 Journal toc kostenfrei https://doaj.org/toc/2338-9109 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2022 1 62-75
allfields_unstemmed	10.32668/jitek.v10i1.938 doi (DE-627)DOAJ085414875 (DE-599)DOAJ36200870d36d4011953d531bd044d0e6 DE-627 ger DE-627 rakwb eng ind R855-855.5 Apriani Apriani verfasserin aut Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients. covid-19 comorbid laboratory tests Medical technology Fenny Ong Lian Hwa verfasserin aut In Jurnal Ilmu dan Teknologi Kesehatan Poltekkes Kemenkes Jakarta III, 2022 10(2022), 1, Seite 62-75 (DE-627)1826854487 23389109 nnns volume:10 year:2022 number:1 pages:62-75 https://doi.org/10.32668/jitek.v10i1.938 kostenfrei https://doaj.org/article/36200870d36d4011953d531bd044d0e6 kostenfrei https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938 kostenfrei https://doaj.org/toc/2338-9095 Journal toc kostenfrei https://doaj.org/toc/2338-9109 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2022 1 62-75
allfieldsGer	10.32668/jitek.v10i1.938 doi (DE-627)DOAJ085414875 (DE-599)DOAJ36200870d36d4011953d531bd044d0e6 DE-627 ger DE-627 rakwb eng ind R855-855.5 Apriani Apriani verfasserin aut Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients. covid-19 comorbid laboratory tests Medical technology Fenny Ong Lian Hwa verfasserin aut In Jurnal Ilmu dan Teknologi Kesehatan Poltekkes Kemenkes Jakarta III, 2022 10(2022), 1, Seite 62-75 (DE-627)1826854487 23389109 nnns volume:10 year:2022 number:1 pages:62-75 https://doi.org/10.32668/jitek.v10i1.938 kostenfrei https://doaj.org/article/36200870d36d4011953d531bd044d0e6 kostenfrei https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938 kostenfrei https://doaj.org/toc/2338-9095 Journal toc kostenfrei https://doaj.org/toc/2338-9109 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2022 1 62-75
allfieldsSound	10.32668/jitek.v10i1.938 doi (DE-627)DOAJ085414875 (DE-599)DOAJ36200870d36d4011953d531bd044d0e6 DE-627 ger DE-627 rakwb eng ind R855-855.5 Apriani Apriani verfasserin aut Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid 2022 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients. covid-19 comorbid laboratory tests Medical technology Fenny Ong Lian Hwa verfasserin aut In Jurnal Ilmu dan Teknologi Kesehatan Poltekkes Kemenkes Jakarta III, 2022 10(2022), 1, Seite 62-75 (DE-627)1826854487 23389109 nnns volume:10 year:2022 number:1 pages:62-75 https://doi.org/10.32668/jitek.v10i1.938 kostenfrei https://doaj.org/article/36200870d36d4011953d531bd044d0e6 kostenfrei https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938 kostenfrei https://doaj.org/toc/2338-9095 Journal toc kostenfrei https://doaj.org/toc/2338-9109 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 10 2022 1 62-75
language	English Indonesian
source	In Jurnal Ilmu dan Teknologi Kesehatan 10(2022), 1, Seite 62-75 volume:10 year:2022 number:1 pages:62-75
sourceStr	In Jurnal Ilmu dan Teknologi Kesehatan 10(2022), 1, Seite 62-75 volume:10 year:2022 number:1 pages:62-75
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	covid-19 comorbid laboratory tests Medical technology
isfreeaccess_bool	true
container_title	Jurnal Ilmu dan Teknologi Kesehatan
authorswithroles_txt_mv	Apriani Apriani @@aut@@ Fenny Ong Lian Hwa @@aut@@
publishDateDaySort_date	2022-01-01T00:00:00Z
hierarchy_top_id	1826854487
id	DOAJ085414875
language_de	englisch Sangiang
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ085414875</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311035035.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.32668/jitek.v10i1.938</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ085414875</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ36200870d36d4011953d531bd044d0e6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">ind</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R855-855.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Apriani Apriani</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">covid-19</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">comorbid</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">laboratory tests</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical technology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Fenny Ong Lian Hwa</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Jurnal Ilmu dan Teknologi Kesehatan</subfield><subfield code="d">Poltekkes Kemenkes Jakarta III, 2022</subfield><subfield code="g">10(2022), 1, Seite 62-75</subfield><subfield code="w">(DE-627)1826854487</subfield><subfield code="x">23389109</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:62-75</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.32668/jitek.v10i1.938</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/36200870d36d4011953d531bd044d0e6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2338-9095</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2338-9109</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="h">62-75</subfield></datafield></record></collection>
callnumber-first	R - Medicine
author	Apriani Apriani
spellingShingle	Apriani Apriani misc R855-855.5 misc covid-19 misc comorbid misc laboratory tests misc Medical technology Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid
authorStr	Apriani Apriani
ppnlink_with_tag_str_mv	@@773@@(DE-627)1826854487
format	electronic Article
delete_txt_mv	keep
author_role	aut aut
collection	DOAJ
remote_str	true
callnumber-label	R855-855
illustrated	Not Illustrated
issn	23389109
topic_title	R855-855.5 Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid covid-19 comorbid laboratory tests
topic	misc R855-855.5 misc covid-19 misc comorbid misc laboratory tests misc Medical technology
topic_unstemmed	misc R855-855.5 misc covid-19 misc comorbid misc laboratory tests misc Medical technology
topic_browse	misc R855-855.5 misc covid-19 misc comorbid misc laboratory tests misc Medical technology
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Jurnal Ilmu dan Teknologi Kesehatan
hierarchy_parent_id	1826854487
hierarchy_top_title	Jurnal Ilmu dan Teknologi Kesehatan
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)1826854487
title	Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid
ctrlnum	(DE-627)DOAJ085414875 (DE-599)DOAJ36200870d36d4011953d531bd044d0e6
title_full	Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid
author_sort	Apriani Apriani
journal	Jurnal Ilmu dan Teknologi Kesehatan
journalStr	Jurnal Ilmu dan Teknologi Kesehatan
callnumber-first-code	R
lang_code	eng ind
isOA_bool	true
recordtype	marc
publishDateSort	2022
contenttype_str_mv	txt
container_start_page	62
author_browse	Apriani Apriani Fenny Ong Lian Hwa
container_volume	10
class	R855-855.5
format_se	Elektronische Aufsätze
author-letter	Apriani Apriani
doi_str_mv	10.32668/jitek.v10i1.938
author2-role	verfasserin
title_sort	profile of laboratory test value in confirmed covid-19 patients with comorbid
callnumber	R855-855.5
title_auth	Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid
abstract	Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients.
abstractGer	Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients.
abstract_unstemmed	Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients.
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	1
title_short	Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid
url	https://doi.org/10.32668/jitek.v10i1.938 https://doaj.org/article/36200870d36d4011953d531bd044d0e6 https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938 https://doaj.org/toc/2338-9095 https://doaj.org/toc/2338-9109
remote_bool	true
author2	Fenny Ong Lian Hwa
author2Str	Fenny Ong Lian Hwa
ppnlink	1826854487
callnumber-subject	R - General Medicine
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.32668/jitek.v10i1.938
callnumber-a	R855-855.5
up_date	2024-07-03T14:36:55.948Z
_version_	1803568981959770112
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000naa a22002652 4500</leader><controlfield tag="001">DOAJ085414875</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230311035035.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230311s2022 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.32668/jitek.v10i1.938</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ085414875</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ36200870d36d4011953d531bd044d0e6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield><subfield code="a">ind</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">R855-855.5</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Apriani Apriani</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Comorbid COVID-19 patients are a vulnerable group. This study aims to describe the characteristics of the laboratory values of COVID-19 patients with comorbidities. This type of research is descriptive observational. The population and sample in this study were patients with confirmed COVID19 at the Siloam Hospital Lippo Village as many as 94 patients. Laboratory values analyzed included Hemoglobin (Hb), Leukocytes (WBC), Platelets (PLT), D-dimer, Lactate dehydrogenase (LDH), C-reactive protein (CRP), and Procalcitonin (PCT). Respondent data and laboratory values were analyzed descriptively, in the form of a summary of data for each variable. Respondent data, mostly in the age range of 50-59 years (33%) and male (53.2%). The most common comorbidities were hypertension (29.8%), Diabetes Mellitus and Chronis Cardiac Disease (16%), Chronic Obstructive Pulmonary and Chronic Kidney Disease (8.5%), Autoimmune and Cancer (10.6%) .The results of laboratory values showed that the average values of D-dimer (2.1 mg/mL), Lactate Dehydrogenase (418.45 mL), C-Reactive Protein (39.69 mg/L) and Procalcitonine (1.59 ng/mL) was increased in all comorbidities. Meanwhile, the examination values of leukocytes, platelets and hemoglobin were in normal condition. The results of these laboratory tests can be used as prognostic predictors and risk of mortality in comorbid COVID-19 patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">covid-19</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">comorbid</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">laboratory tests</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical technology</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Fenny Ong Lian Hwa</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Jurnal Ilmu dan Teknologi Kesehatan</subfield><subfield code="d">Poltekkes Kemenkes Jakarta III, 2022</subfield><subfield code="g">10(2022), 1, Seite 62-75</subfield><subfield code="w">(DE-627)1826854487</subfield><subfield code="x">23389109</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:10</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:62-75</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.32668/jitek.v10i1.938</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/36200870d36d4011953d531bd044d0e6</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ejurnal.poltekkesjakarta3.ac.id/index.php/jitek/article/view/938</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2338-9095</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/2338-9109</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">10</subfield><subfield code="j">2022</subfield><subfield code="e">1</subfield><subfield code="h">62-75</subfield></datafield></record></collection>
score	7.401758

Nicht das Richtige dabei?

Schreiben Sie uns!

Profile of Laboratory Test Value in Confirmed COVID-19 Patients with Comorbid

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?